ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

URGN UroGen Pharma Ltd

14,30
0,04 (0,28%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
UroGen Pharma Ltd URGN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,04 0,28% 14,30 01:22:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
14,50 14,14 14,70 14,30 14,26
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
04.5.202421:20BWUroGen Announces Results from ATLAS Showing Robust UGN-102..
04.5.202417:50BWNew Real-World Study on Retrograde Instillation of JELMYTO®..
03.5.202414:00BWUroGen Pharma to Report 2024 First Quarter Financial Results..
17.4.202418:02BWUroGen Announces New Data Presentations at the American..
15.4.202414:00BWUroGen Announces FDA Acceptance of Investigational New Drug..
03.4.202414:00BWUroGen Pharma Files Patent Infringement Action Against Teva..
14.3.202413:00BWUroGen Pharma Delivers Double Digit JELMYTO® Growth and..
08.3.202414:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
04.3.202414:00BWUroGen Pharma to Report Fourth Quarter and Full-Year 2023..
04.3.202413:00EDGAR2Form 8-K - Current report
01.3.202413:00EDGAR2Form 8-K - Current report
26.2.202414:00BWUroGen Pharma to Present at TD Cowen 44th Annual Health Care..
12.2.202423:47EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
07.2.202422:15EDGAR2Form 8-K - Current report
03.2.202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202416:13EDGAR2Form 144 - Report of proposed sale of securities
01.2.202415:53EDGAR2Form 144 - Report of proposed sale of securities
01.2.202414:00BWUroGen Pharma to Participate at Upcoming Investor..
24.1.202414:00BWUroGen Initiates Submission of a Rolling NDA to the FDA for..
17.1.202422:16EDGAR2Form 8-K - Current report
17.1.202414:00BWUroGen Secures Exclusive License from medac GmbH to Develop..
11.1.202414:00BWUroGen Pharma to Participate in the B. Riley Healthcare..
02.1.202414:04EDGAR2Form 8-K - Current report
08.12.202322:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
14.11.202322:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
14.11.202314:00BWUroGen Pharma Reports Third Quarter 2023 Financial Results
13.11.202314:00BWUroGen will Present Scientific Advances in Bladder Cancer at..
07.11.202314:00BWUroGen Pharma to Report Third Quarter 2023 Financial Results..
03.10.202314:00BWFollowing Pre-NDA Meeting with the FDA, UroGen Announces..
11.9.202322:15EDGAR2Form 8-K - Current report
11.9.202313:00GLOBEEledon Pharmaceuticals Appoints Industry Veteran James..
08.9.202322:16EDGAR2Form S-3 - Registration statement under Securities Act of..
08.9.202321:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202321:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202321:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202321:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202321:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202321:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202321:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202314:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
05.9.202322:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.8.202314:00BWUroGen Pharma to Present at Upcoming Investor Conferences
10.8.202314:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202314:01EDGAR2Form 8-K - Current report
10.8.202314:00BWUroGen Pharma Reports Record JELMYTO Quarterly Sales and..
08.8.202314:00BWThe Journal of Urology Publishes Peer-Reviewed Article..
04.8.202314:56EDGAR2Form SC 13D - General statement of acquisition of beneficial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock